Global Hyperhidrosis Drugs Supply, Demand and Key Producers, 2023-2029

May 2023 | 96 pages | ID: GCD86C52F63DEN
GlobalInfoResearch

Abstracts

The global Hyperhidrosis Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Hyperhidrosis Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hyperhidrosis Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperhidrosis Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Hyperhidrosis Drugs total market, 2018-2029, (USD Million)

Global Hyperhidrosis Drugs total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Hyperhidrosis Drugs total market, key domestic companies and share, (USD Million)

Global Hyperhidrosis Drugs revenue by player and market share 2018-2023, (USD Million)

Global Hyperhidrosis Drugs total market by Type, CAGR, 2018-2029, (USD Million)

Global Hyperhidrosis Drugs total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Hyperhidrosis Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, GlaxoSmithKline, Journey Medical Corporation, Carpe, Duradry, BTXA, Seaford Pharmaceuticals and Robugen GmbH, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperhidrosis Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hyperhidrosis Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Hyperhidrosis Drugs Market, Segmentation by Type

• Botulinum Toxin Injections
• Topical Medication
• Oral Medication

Global Hyperhidrosis Drugs Market, Segmentation by Application

• Primary Focal Hyperhidrosis
• Secondary Generalized Hyperhidrosis

Companies Profiled:

• Allergan
• GlaxoSmithKline
• Journey Medical Corporation
• Carpe
• Duradry
• BTXA
• Seaford Pharmaceuticals
• Robugen GmbH

Key Questions Answered

1. How big is the global Hyperhidrosis Drugs market?

2. What is the demand of the global Hyperhidrosis Drugs market?

3. What is the year over year growth of the global Hyperhidrosis Drugs market?

4. What is the total value of the global Hyperhidrosis Drugs market?

5. Who are the major players in the global Hyperhidrosis Drugs market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Hyperhidrosis Drugs Introduction
1.2 World Hyperhidrosis Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Hyperhidrosis Drugs Total Market by Region (by Headquarter Location)
  1.3.1 World Hyperhidrosis Drugs Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.3 China Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.4 Europe Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.5 Japan Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.6 South Korea Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.7 ASEAN Hyperhidrosis Drugs Market Size (2018-2029)
  1.3.8 India Hyperhidrosis Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Hyperhidrosis Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Hyperhidrosis Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Hyperhidrosis Drugs Consumption Value (2018-2029)
2.2 World Hyperhidrosis Drugs Consumption Value by Region
  2.2.1 World Hyperhidrosis Drugs Consumption Value by Region (2018-2023)
  2.2.2 World Hyperhidrosis Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Hyperhidrosis Drugs Consumption Value (2018-2029)
2.4 China Hyperhidrosis Drugs Consumption Value (2018-2029)
2.5 Europe Hyperhidrosis Drugs Consumption Value (2018-2029)
2.6 Japan Hyperhidrosis Drugs Consumption Value (2018-2029)
2.7 South Korea Hyperhidrosis Drugs Consumption Value (2018-2029)
2.8 ASEAN Hyperhidrosis Drugs Consumption Value (2018-2029)
2.9 India Hyperhidrosis Drugs Consumption Value (2018-2029)

3 WORLD HYPERHIDROSIS DRUGS COMPANIES COMPETITIVE ANALYSIS

3.1 World Hyperhidrosis Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Hyperhidrosis Drugs Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Hyperhidrosis Drugs in 2022
  3.2.3 Global Concentration Ratios (CR8) for Hyperhidrosis Drugs in 2022
3.3 Hyperhidrosis Drugs Company Evaluation Quadrant
3.4 Hyperhidrosis Drugs Market: Overall Company Footprint Analysis
  3.4.1 Hyperhidrosis Drugs Market: Region Footprint
  3.4.2 Hyperhidrosis Drugs Market: Company Product Type Footprint
  3.4.3 Hyperhidrosis Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Hyperhidrosis Drugs Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Hyperhidrosis Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Hyperhidrosis Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Hyperhidrosis Drugs Consumption Value Comparison
  4.2.1 United States VS China: Hyperhidrosis Drugs Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Hyperhidrosis Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Hyperhidrosis Drugs Companies and Market Share, 2018-2023
  4.3.1 United States Based Hyperhidrosis Drugs Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Hyperhidrosis Drugs Revenue, (2018-2023)
4.4 China Based Companies Hyperhidrosis Drugs Revenue and Market Share, 2018-2023
  4.4.1 China Based Hyperhidrosis Drugs Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Hyperhidrosis Drugs Revenue, (2018-2023)
4.5 Rest of World Based Hyperhidrosis Drugs Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Hyperhidrosis Drugs Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Hyperhidrosis Drugs Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Hyperhidrosis Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Botulinum Toxin Injections
  5.2.2 Topical Medication
  5.2.3 Oral Medication
5.3 Market Segment by Type
  5.3.1 World Hyperhidrosis Drugs Market Size by Type (2018-2023)
  5.3.2 World Hyperhidrosis Drugs Market Size by Type (2024-2029)
  5.3.3 World Hyperhidrosis Drugs Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Hyperhidrosis Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Primary Focal Hyperhidrosis
  6.2.2 Secondary Generalized Hyperhidrosis
6.3 Market Segment by Application
  6.3.1 World Hyperhidrosis Drugs Market Size by Application (2018-2023)
  6.3.2 World Hyperhidrosis Drugs Market Size by Application (2024-2029)
  6.3.3 World Hyperhidrosis Drugs Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Allergan
  7.1.1 Allergan Details
  7.1.2 Allergan Major Business
  7.1.3 Allergan Hyperhidrosis Drugs Product and Services
  7.1.4 Allergan Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Allergan Recent Developments/Updates
  7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Details
  7.2.2 GlaxoSmithKline Major Business
  7.2.3 GlaxoSmithKline Hyperhidrosis Drugs Product and Services
  7.2.4 GlaxoSmithKline Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 GlaxoSmithKline Recent Developments/Updates
  7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.3 Journey Medical Corporation
  7.3.1 Journey Medical Corporation Details
  7.3.2 Journey Medical Corporation Major Business
  7.3.3 Journey Medical Corporation Hyperhidrosis Drugs Product and Services
  7.3.4 Journey Medical Corporation Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Journey Medical Corporation Recent Developments/Updates
  7.3.6 Journey Medical Corporation Competitive Strengths & Weaknesses
7.4 Carpe
  7.4.1 Carpe Details
  7.4.2 Carpe Major Business
  7.4.3 Carpe Hyperhidrosis Drugs Product and Services
  7.4.4 Carpe Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Carpe Recent Developments/Updates
  7.4.6 Carpe Competitive Strengths & Weaknesses
7.5 Duradry
  7.5.1 Duradry Details
  7.5.2 Duradry Major Business
  7.5.3 Duradry Hyperhidrosis Drugs Product and Services
  7.5.4 Duradry Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Duradry Recent Developments/Updates
  7.5.6 Duradry Competitive Strengths & Weaknesses
7.6 BTXA
  7.6.1 BTXA Details
  7.6.2 BTXA Major Business
  7.6.3 BTXA Hyperhidrosis Drugs Product and Services
  7.6.4 BTXA Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 BTXA Recent Developments/Updates
  7.6.6 BTXA Competitive Strengths & Weaknesses
7.7 Seaford Pharmaceuticals
  7.7.1 Seaford Pharmaceuticals Details
  7.7.2 Seaford Pharmaceuticals Major Business
  7.7.3 Seaford Pharmaceuticals Hyperhidrosis Drugs Product and Services
  7.7.4 Seaford Pharmaceuticals Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Seaford Pharmaceuticals Recent Developments/Updates
  7.7.6 Seaford Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Robugen GmbH
  7.8.1 Robugen GmbH Details
  7.8.2 Robugen GmbH Major Business
  7.8.3 Robugen GmbH Hyperhidrosis Drugs Product and Services
  7.8.4 Robugen GmbH Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Robugen GmbH Recent Developments/Updates
  7.8.6 Robugen GmbH Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Hyperhidrosis Drugs Industry Chain
8.2 Hyperhidrosis Drugs Upstream Analysis
8.3 Hyperhidrosis Drugs Midstream Analysis
8.4 Hyperhidrosis Drugs Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Hyperhidrosis Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Hyperhidrosis Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Hyperhidrosis Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Hyperhidrosis Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Hyperhidrosis Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Hyperhidrosis Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Hyperhidrosis Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Hyperhidrosis Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Hyperhidrosis Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Hyperhidrosis Drugs Players in 2022
Table 12. World Hyperhidrosis Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Hyperhidrosis Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Hyperhidrosis Drugs Player
Table 15. Hyperhidrosis Drugs Market: Company Product Type Footprint
Table 16. Hyperhidrosis Drugs Market: Company Product Application Footprint
Table 17. Hyperhidrosis Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Hyperhidrosis Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Hyperhidrosis Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Hyperhidrosis Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Hyperhidrosis Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Hyperhidrosis Drugs Revenue Market Share (2018-2023)
Table 23. China Based Hyperhidrosis Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Hyperhidrosis Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Hyperhidrosis Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Hyperhidrosis Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Hyperhidrosis Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Hyperhidrosis Drugs Revenue Market Share (2018-2023)
Table 29. World Hyperhidrosis Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Hyperhidrosis Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Hyperhidrosis Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Hyperhidrosis Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Hyperhidrosis Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Hyperhidrosis Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Allergan Basic Information, Area Served and Competitors
Table 36. Allergan Major Business
Table 37. Allergan Hyperhidrosis Drugs Product and Services
Table 38. Allergan Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Allergan Recent Developments/Updates
Table 40. Allergan Competitive Strengths & Weaknesses
Table 41. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 42. GlaxoSmithKline Major Business
Table 43. GlaxoSmithKline Hyperhidrosis Drugs Product and Services
Table 44. GlaxoSmithKline Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. GlaxoSmithKline Recent Developments/Updates
Table 46. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 47. Journey Medical Corporation Basic Information, Area Served and Competitors
Table 48. Journey Medical Corporation Major Business
Table 49. Journey Medical Corporation Hyperhidrosis Drugs Product and Services
Table 50. Journey Medical Corporation Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Journey Medical Corporation Recent Developments/Updates
Table 52. Journey Medical Corporation Competitive Strengths & Weaknesses
Table 53. Carpe Basic Information, Area Served and Competitors
Table 54. Carpe Major Business
Table 55. Carpe Hyperhidrosis Drugs Product and Services
Table 56. Carpe Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Carpe Recent Developments/Updates
Table 58. Carpe Competitive Strengths & Weaknesses
Table 59. Duradry Basic Information, Area Served and Competitors
Table 60. Duradry Major Business
Table 61. Duradry Hyperhidrosis Drugs Product and Services
Table 62. Duradry Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Duradry Recent Developments/Updates
Table 64. Duradry Competitive Strengths & Weaknesses
Table 65. BTXA Basic Information, Area Served and Competitors
Table 66. BTXA Major Business
Table 67. BTXA Hyperhidrosis Drugs Product and Services
Table 68. BTXA Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. BTXA Recent Developments/Updates
Table 70. BTXA Competitive Strengths & Weaknesses
Table 71. Seaford Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Seaford Pharmaceuticals Major Business
Table 73. Seaford Pharmaceuticals Hyperhidrosis Drugs Product and Services
Table 74. Seaford Pharmaceuticals Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Seaford Pharmaceuticals Recent Developments/Updates
Table 76. Robugen GmbH Basic Information, Area Served and Competitors
Table 77. Robugen GmbH Major Business
Table 78. Robugen GmbH Hyperhidrosis Drugs Product and Services
Table 79. Robugen GmbH Hyperhidrosis Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Hyperhidrosis Drugs Upstream (Raw Materials)
Table 81. Hyperhidrosis Drugs Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Hyperhidrosis Drugs Picture
Figure 2. World Hyperhidrosis Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hyperhidrosis Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Hyperhidrosis Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Hyperhidrosis Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Hyperhidrosis Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Hyperhidrosis Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Hyperhidrosis Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Hyperhidrosis Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Hyperhidrosis Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Hyperhidrosis Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Hyperhidrosis Drugs Markets in 2022
Figure 27. United States VS China: Hyperhidrosis Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hyperhidrosis Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Hyperhidrosis Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Hyperhidrosis Drugs Market Size Market Share by Type in 2022
Figure 31. Botulinum Toxin Injections
Figure 32. Topical Medication
Figure 33. Oral Medication
Figure 34. World Hyperhidrosis Drugs Market Size Market Share by Type (2018-2029)
Figure 35. World Hyperhidrosis Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Hyperhidrosis Drugs Market Size Market Share by Application in 2022
Figure 37. Primary Focal Hyperhidrosis
Figure 38. Secondary Generalized Hyperhidrosis
Figure 39. Hyperhidrosis Drugs Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source